We are a pharmaceutical contract development and manufacturing organization (“CDMO”) offering a comprehensive range of pharmaceutical products and services
Following the acquisition of Parabolic Drugs by our Company in 2021, we entered the business of the manufacture and sale of key starting materials, intermediates and APIs
MGC Pharma meets the escalating demand for health and wellness products with expertise and precision translating nutraceutical concepts into tangible products